Clondalkin Pharma & Healthcare North America Improves Printing Capabilities with High-tech Press
Clondalkin Pharma & Healthcare North America has installed a new four-color offset printing press in its Greensboro, NC plant thereby greatly enhancing the company's capabilities at the facility.
The new press allows for sheeting up to 44" making Clondalkin Pharma & Healthcare North America the first supplier in the industry with the ability to sheet to that size. In addition, the press features UV curing, a "Butler Splicer", and a 100% web vision system to aid in the identification of print defects.
"Clondalkin chose Muller Martini's Alprinta 74 web press because they are the leaders in web press technology for printing on light weight pharmaceutical papers," said David Brown, Vice President of Technology at Clondalkin Pharma & Healthcare North America, "The four-color Alprinta 74 is customized to print a web width of 30" and a length of 40" giving Clondalkin Pharma & Healthcare North America the added capability over our competitors to produce larger size outserts more economically."
In addition to the ability to print in four colors, the new press allows Clondalkin Pharma & Healthcare North America to print with Benzophenone-free UV inks which offer greater clarity and print quality than conventional inks. Since they also cure more quickly than their conventional counterparts, the new inks allow for an increase in production speed because materials flow to subsequent processes faster.
"We are pleased to announce the addition of a new four-color web press to our literature department," said Ernie Chaplin, Vice President of Marketing at Clondalkin Pharma & Healthcare North America, "The press represents our continued commitment of capital investments to improve our processes, expand our capability, and increase our capacity."
The new press was installed during the first week of January, 2011 and is the second of three Alprinta presses purchased from Muller Martini in the last two years. The new press with the large sheeting capabilities will allow Clondalkin Pharma & Healthcare North America to run "large format" inserts on a roll press. The new method is more efficient and is by far the fastest growing segment within the folded literature sector.
Clondalkin Pharma & Healthcare North America, formerly Keller Crescent, is a leading supplier of secondary packaging products in North America for the pharmaceutical and healthcare industries, supplying printed pharmaceutical folding cartons, inserts and outserts, pharmaceutical labels, patient booklets, IV hanger labels, and several patented specialty products - including the latest in track-n-trace and e-pedigree technologies.
Nine strategic locations combine with industry expertise in converting various styles of cartons, inserts and labels to make Clondalkin Pharma & Healthcare North America the source where quality, creativity and compliance connect for the pharmaceutical industry.